NICE renews major health improvement partnership with MAHSC
A major collaboration between
Manchester and the National Institute for Health and Care
Excellence (NICE) has been renewed for a further three years, after
making significant achievements in contributing to the assessment
of new drugs and medical technologies, and supporting development
of new treatment guidelines and quality standards for conditions
ranging from cancer and diabetes to heart disease and
NICE has agreed a second Memorandum of Understanding with the
Manchester Academic Health Science Centre (MAHSC) and The
University of Manchester to extend their successful
collaboration. Sir Andrew Dillon, Chief Executive of NICE;
Professor Dame Nancy Rothwell, President and Vice Chancellor of The
University of Manchester; and Professor Ian Jacobs, Dean of the
Faculty of Medical and Human Sciences and Director of MAHSC, signed
the Memorandum on behalf of their respective organisations today
NICE and MAHSC share a commitment to improving the overall
health of the population, through informing health policy and
practice and in developing and evaluating health technologies.
MAHSC is dedicated to translating research discoveries into new
patient treatments, identifying unmet clinical need and applying
research and innovation to meeting this need, and delivering
improved patient care through its NHS partners. The University of
Manchester is the lead research and teaching member for MAHSC.
Key collaborative successes to date include:
- Manchester Pharmacy School developing a series of 20 e-learning
tools for NICE.
- Clinical and research experts joining NICE teams appraising new
drugs and diagnostic testing for lung cancer and developing
guidelines for the treatment of Non-Hodgkin lymphoma.
- Contributing to the development of NICE guidelines and quality
standards for treating patients with psoriasis and colorectal
- Taking part in the NICE advisory panel on new medical
technologies and appraising new diagnostic tools.
- Creating the North West Evidence Synthesis Network to share
ideas on how to assess evidence relating to research findings and
treatments, and so help to inform policy and decision making in the
- NICE colleagues appointed as honorary University staff and
helping to develop and deliver postgraduate training courses in
evidence based population health, communicable disease control and
public health leadership.
Congratulating the partners on a very successful three years,
Sir Andrew Dillon said:
"Our relationship has been a very fruitful one because of our
shared commitments to using the very best science and evidence to
improve the health of our population. Translating research into
better patient care and training the healthcare professionals of
tomorrow are vital in this endeavour, and I'm delighted that this
partnership is making this happen. We look forward to many more
years of successes."
Professor Ian Jacobs said: "This important collaboration has
enabled us to link the skills of experts in research, patient care
and policy-making between NICE, MAHSC and the University of
Manchester. It is part of our drive to improve quality and achieve
better outcomes for patients whilst supporting the interactions
with innovative health technology companies. Partnership with
NICE has been an exciting development for us across research,
teaching and innovation."
Added Professor Dame Nancy Rothwell: "We are delighted
to be able to extend the strong relationship Manchester has built
with NICE, and play our part in shaping the future of healthcare in
the UK and internationally."
The new Memorandum of Understanding is particularly focused on
health technologies and public health, drawing on both NICE's
expertise and a number of MAHSC programmes and University research
groupings including: the MAHSC Population Health Domain, University
Institute of Population Health, Manchester: Integrating Medicine
and Innovative Technology (MIMIT), Manchester Health E-Research
Centre and Farr Institute, NorthWest EHealth (NWEH), NIHR Greater
Manchester Collaboration for Leadership in Applied Health Research
and Care (CLAHRC) and Nowgen.
An early area of work under the new Memorandum is focused on
developing an early stage assessment tool to help companies,
particularly SMEs, understand how best to prepare for working with
NICE and to develop an evidence base for their technologies.
For more information, please contact:
NICE press office. Tel: 0300 323 0142. Email: email@example.com
Sarah Glenister, Communications Specialist, MAHSC. Tel:
+44(0)161 701 0435 (Mon, Tues, Fri); or +44 (0)161 306 1695 (Wed,
Thurs). Email: firstname.lastname@example.org
Alison Barbuti, Media Relations Officer for Faculty of Medical
and Human Sciences, The University of Manchester. Tel: +44 (0)161
275 8383 Email: email@example.com
Institute for Health and Care Excellence (NICE) is the
independent body responsible for driving improvement and excellence
in the health and social care system. We develop guidance,
standards and information on high-quality health and social care.
We also advise on ways to promote healthy living and prevent ill
Our aim is to help
practitioners deliver the best possible care and give people the
most effective treatments, which are based on the most up-to-date
evidence and provide value for money, in order to reduce
inequalities and variation.
Our products and resources
are produced for the NHS, local authorities, care providers,
charities, and anyone who has a responsibility for commissioning or
providing healthcare, public health or social care services.
To find out more about what
we do, visit our website: http://www.nice.org.uk and
follow us on Twitter: @NICEComms.
MAHSC (the Manchester Academic Health Science
Centre) is a partnership between The University of Manchester and
six NHS organisations. Our NHS partners are some of the most highly
rated NHS Trusts in the country, and The University of Manchester
is one of the top three UK research universities (RAE 2008). We are
proud to be one of only six centres in the country currently
designated as an AHSC. AHSC designation recognises excellence
across research, innovation, education and patient service, and in
particular the potential to excel in translational medicine.
Through partnership with the Greater Manchester Academic Health
Science Network, MAHSC acts as a beacon within the local health
system, providing clinical leadership and helping health care
organisations reap the benefits of research and innovation to drive
improvements in care. www.mahsc.ac.uk
The MAHSC partners are:
• The University of Manchester
• Central Manchester University Hospitals NHS Foundation
• Manchester Mental Health and Social Care Trust
• Salford CCG (formerly NHS Salford) as lead representative for
• Salford Royal NHS Foundation Trust
• The Christie NHS Foundation Trust
• University Hospital of South Manchester NHS Foundation
The University of Manchester, a member of the
Russell Group, is one of the largest and most popular universities
in the UK. It has 20 academic schools and hundreds of specialist
research groups undertaking pioneering multi-disciplinary teaching
and research of worldwide significance. According to the results of
the 2008 Research Assessment Exercise, The University of Manchester
is one of the country's major research institutions, rated third in
the UK in terms of 'research power'. The University has an annual
income of £807 million and is ranked 40th in the world and fifth in
the UK for the quality of its teaching and impact of its research.